Testing times in fight against TB
A Central programme that has sequenced thousands of TB bacterial genomes could improve drug resistance testing.
Boost for biologics
A homegrown ancillary sector may give a leg-up to India’s biotech ambitions. But these are early days.
To catch 'em young
Researchers and start-ups are turning to microRNAs for early detection of critical illnesses.
Outlook positive
A maturing ecosystem, with alternative sources for funding, bodes well for deep tech start-ups in the healthcare space.
